Literature DB >> 30244120

The toxic effects of monosodium glutamate (MSG) - The involvement of nitric oxide, prostanoids and potassium channels in the reactivity of thoracic arteries in MSG-obese rats.

Michał Majewski1, Adam Jurgoński2, Bartosz Fotschki2, Jerzy Juśkiewicz2.   

Abstract

We investigated the potential effects of monosodium glutamate (MSG)-induced obesity with regards to nitric oxide and prostanoid production, as well as potassium channel function, in rat thoracic arteries. Newborn male Wistar rats were injected intraperitoneally with typically reported MSG (4.0 mg/g) once daily for 4 consecutive days. At 90 days postnatal, the rats were sacrificed and the thoracic aortas were evaluated for vascular responses and for prostanoid production. Nitric oxide was studied with calcium ionophore (A23187), acetylcholine (ACh) and sodium nitroprusside (SNP). The release of prostanoids was measured under basal and ACh-stimulated conditions, and the vasomotor effect of exogenous thromboxane A2 mimetic, U46619 was assessed. Potassium channel activities were analyzed using an NS1619 opener for BKCa channels and pinacidil for KATP channels. Arteries from MSG-obese rats exhibited a reduced maximal contraction to potassium chloride and hyper-responsiveness to U46619, suggesting that MSG also alters the responsiveness of vascular smooth muscles. The endothelium-dependent relaxation to ACh and A23817 was attenuated, suggesting low nitric oxide bioavailability. The hypersensitivity of arteries to an exogenous nitric oxide donor, SNP, occurred. The secondary contraction to A23817 was augmented, suggesting increased activation of the prostanoid receptor. The prostanoid release was increased in both basal- and acetylcholine-stimulated rings. In addition, down-regulation of KATP and BKCa channels influenced hyperpolarizing mechanisms. Our findings suggest that increased prostanoid production and hypersensitivity to thromboxane A2 together with down-regulation of potassium channels and low nitric oxide bioavailability may contribute to the increase in blood pressure found in adult MSG-obese male rats.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Monosodium glutamate; Nitric oxide; Obesity; Potassium channels; Thromboxane A(2)

Mesh:

Substances:

Year:  2018        PMID: 30244120     DOI: 10.1016/j.taap.2018.09.016

Source DB:  PubMed          Journal:  Toxicol Appl Pharmacol        ISSN: 0041-008X            Impact factor:   4.219


  5 in total

1.  A metagenome-wide association study of gut microbiome and visceral fat accumulation.

Authors:  Xiaomin Nie; Jiarui Chen; Xiaojing Ma; Yueqiong Ni; Yun Shen; Haoyong Yu; Gianni Panagiotou; Yuqian Bao
Journal:  Comput Struct Biotechnol J       Date:  2020-09-20       Impact factor: 7.271

2.  The Characterization of Ground Raspberry Seeds and the Physiological Response to Supplementation in Hypertensive and Normotensive Rats.

Authors:  Michał Majewski; Ewa Kucharczyk; Roman Kaliszan; Michał Markuszewski; Bartosz Fotschki; Jerzy Juśkiewicz; Małgorzata Borkowska-Sztachańska; Katarzyna Ognik
Journal:  Nutrients       Date:  2020-06-01       Impact factor: 5.717

3.  The Role of 20-HETE, COX, Thromboxane Receptors, and Blood Plasma Antioxidant Status in Vascular Relaxation of Copper-Nanoparticle-Fed WKY Rats.

Authors:  Michał Majewski; Jerzy Juśkiewicz; Magdalena Krajewska-Włodarczyk; Leszek Gromadziński; Katarzyna Socha; Ewelina Cholewińska; Katarzyna Ognik
Journal:  Nutrients       Date:  2021-10-26       Impact factor: 5.717

4.  Dietary supplementation with copper nanoparticles influences the markers of oxidative stress and modulates vasodilation of thoracic arteries in young Wistar rats.

Authors:  Michał Majewski; Bernadetta Lis; Beata Olas; Katarzyna Ognik; Jerzy Juśkiewicz
Journal:  PLoS One       Date:  2020-02-21       Impact factor: 3.240

Review 5.  Oxidative Stress and Vascular Damage in the Context of Obesity: The Hidden Guest.

Authors:  Ernesto Martínez-Martínez; Francisco V Souza-Neto; Sara Jiménez-González; Victoria Cachofeiro
Journal:  Antioxidants (Basel)       Date:  2021-03-08
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.